Testosterone dose-dependently increases maximal voluntary strength and leg power, but does not affect fatigability or specific tension.
about
The safety, pharmacokinetics, and effects of LGD-4033, a novel nonsteroidal oral, selective androgen receptor modulator, in healthy young menAdverse events associated with testosterone administrationTestosterone for the aging male; current evidence and recommended practiceDiscovery and therapeutic promise of selective androgen receptor modulatorsDo fat supplements increase physical performance?Influence of androgens on circulating adiponectin in male and female rodentsPhysical activity and risk of Amyotrophic Lateral Sclerosis in a prospective cohort studyAdverse health consequences of performance-enhancing drugs: an Endocrine Society scientific statement.Treatment with oxandrolone and the durability of effects in older men.Effects of a supraphysiological dose of testosterone on physical function, muscle performance, mood, and fatigue in men with HIV-associated weight loss.Sildenafil increases muscle protein synthesis and reduces muscle fatigue.Free testosterone levels are associated with mobility limitation and physical performance in community-dwelling men: the Framingham Offspring StudySelective androgen receptor modulators as function promoting therapies.Drug abuse in athletes.Effects of long term supplementation of anabolic androgen steroids on human skeletal muscle.Characterization of GLPG0492, a selective androgen receptor modulator, in a mouse model of hindlimb immobilizationDihydrotestosterone ameliorates degeneration in muscle, axons and motoneurons and improves motor function in amyotrophic lateral sclerosis model mice.Out of bounds? A critique of the new policies on hyperandrogenism in elite female athletesWhy is muscularity sexy? Tests of the fitness indicator hypothesis.Skeletal muscle wasting in cachexia and sarcopenia: molecular pathophysiology and impact of exercise training.Endocrinology of the aging male.Body composition changes and inhibition of fat development in vivo implicates androgen in regulation of stem cell lineage allocation.Clinical meaningfulness of the changes in muscle performance and physical function associated with testosterone administration in older men with mobility limitationTestosterone metabolism, dose-response relationships and receptor polymorphisms: selected pharmacological/toxicological considerations on benefits versus risks of testosterone therapy in men.Testosterone and sport: current perspectives.DESIGNING DRUG TRIALS FOR SARCOPENIA IN OLDER ADULTS WITH HIP FRACTURE - A TASK FORCE FROM THE INTERNATIONAL CONFERENCE ONFRAILTY AND SARCOPENIA RESEARCH (ICFSR).Pulmonary rehabilitation in chronic obstructive pulmonary disease.Drug insight: Testosterone and selective androgen receptor modulators as anabolic therapies for chronic illness and agingAdvances in male hormone substitution therapy.National Athletic Trainers' Association position statement: anabolic-androgenic steroids.Testosterone dose-response relationships in hysterectomized women with or without oophorectomy: effects on sexual function, body composition, muscle performance and physical function in a randomized trial.Indirect androgen doping by oestrogen blockade in sports.Changes in muscle mass, muscle strength, and power but not physical function are related to testosterone dose in healthy older men.The significance of testosterone for fair participation of the female sex in competitive sportsTestosterone treatment of hypogonadal men participating in competitive sports.An exploration of the association between frailty and muscle fatigue.Enhanced muscle fatigue occurs in male but not female ASIC3-/- mice.Effect of nandrolone decanoate administration on recovery from bupivacaine-induced muscle injury.Association between testosterone and estradiol and age-related decline in physical function in a diverse sample of menAndrogen effects on skeletal muscle: implications for the development and management of frailty.
P2860
Q24561868-22376E42-EE72-4A97-A3FE-1B2936F34F37Q24601802-5900F316-E9BB-4E80-ABDA-6C549F2AC45FQ24647679-522B7BD2-53E5-407C-A8CF-98BC27150D37Q24680356-05A7E879-4CF8-43AA-8BF2-72E065DEC6AFQ26825805-B3C259AE-B4E3-4550-84F2-049CB6E15188Q27314775-4C0FB403-8C4E-4E94-9778-875ABAA443A6Q28391291-3A895C79-A312-4AFE-9F1B-D81149B89032Q30409171-B462335D-6D61-4940-8D1F-1E783797B413Q30882835-4FAC4657-434A-4DAB-8B6A-4BE5E351FF46Q33330243-A9C770E4-8B6F-45F3-86E1-9E6ECBE77C74Q33827719-8C00E9BD-E507-4EAA-8715-B6C289F9311CQ33984860-E06B5B78-3417-456B-956C-F27E6030CCFDQ34007493-5CCF1745-54D6-4493-9E0A-7DFB3A04EF97Q34075256-E17EE5A6-8A49-49AC-9FE8-DEE140623356Q34160098-71CD5B16-14AA-4D30-979E-1B4804C1E04AQ34203697-8870ED7C-492A-47F5-9DD5-E14B58994629Q34273954-0BB4406E-DA0E-4310-A884-9EFC38E39FA4Q34281138-25952231-7F96-4C46-8302-A22CC9CA080DQ34639293-CB669C8C-90DC-49CB-88CC-80DDD081AB48Q34697114-4E82D4D1-B063-4E35-8ABF-A969E372DCD7Q34777308-1F5B7513-23EB-43F7-B81A-FF0F2C43ECC6Q35036928-3580A40F-BB50-407F-AE12-695C1768F6CFQ35459531-C7F62B74-4B00-44C1-AF07-B049F5CC2C4DQ35684578-9CA00454-FE2D-4CDF-992F-1BD815EB21B6Q35690905-878A5303-54B1-42BB-95C3-D64AD3D7815AQ36057081-4529A518-18F5-4A5D-BC3E-5403BB1BEEC7Q36075213-22837FF2-B1E6-4E90-98CA-51429CBD34A3Q36130944-FA4684FC-8E61-4741-83F4-6B5B513D5F31Q36221968-C40C2E78-D21B-46C1-9D7C-B4DD6D2258A3Q36299949-4FCA7B9A-8D91-42BC-8749-A08BBA30B429Q36430047-1A2A190A-454E-4704-8AC5-E8631CC9BFB8Q36736110-BD75E994-0C84-44B8-AE84-01380373023CQ36978134-7C879D68-BF7A-47B7-B851-77EE9C68A7CAQ37085281-F2303BF6-5E1B-4D06-BC7C-280551E9F2C3Q37162673-A4FA68A7-FDBA-4C21-BB2A-012E1D494C1CQ37222255-C425DA73-FF9B-442F-9191-AF2BE3D9E063Q37352915-9F0E6182-235E-483D-8B01-7F85B11AA013Q37422180-B547B62F-5BA9-4921-9F81-4CF264C11FEBQ37453660-4BDBF6C1-9C1B-4465-A90F-DABA7F2B4FD1Q37639192-BF4F391A-020E-4037-8CDC-C37392E9B14C
P2860
Testosterone dose-dependently increases maximal voluntary strength and leg power, but does not affect fatigability or specific tension.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Testosterone dose-dependently ...... igability or specific tension.
@en
Testosterone dose-dependently ...... igability or specific tension.
@nl
type
label
Testosterone dose-dependently ...... igability or specific tension.
@en
Testosterone dose-dependently ...... igability or specific tension.
@nl
prefLabel
Testosterone dose-dependently ...... igability or specific tension.
@en
Testosterone dose-dependently ...... igability or specific tension.
@nl
P2093
P356
P1476
Testosterone dose-dependently ...... igability or specific tension.
@en
P2093
Connie Dzekov
Jeanne Dzekov
Linda Woodhouse
Lynne Magliano
Martin L Lee
Richard Casaburi
Thomas W Storer
P304
P356
10.1210/JC.2002-021231
P407
P577
2003-04-01T00:00:00Z